AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpure MV 2.3 Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimpure MV 2.3 Tablet

Diabetic patients using Glimpure MV 2.3 tablets, an anti-diabetic combination medication, should adhere to prescribed dosages for effective type 2 diabetes management in adults. This medication regulates blood glucose levels, and consistent daily intake, ideally with meals, maximizes therapeutic benefits. Dosage adjustments are determined by your physician based on blood sugar monitoring. Discontinuing this medicine without medical consultation risks elevated blood sugar, potentially leading to complications including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, Glimpure MV 2.3 forms part of a comprehensive diabetes management plan that necessitates a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Common side effects include hypoglycemia (low blood sugar), manifested by symptoms like sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source, such as juice or sweets, to counteract this. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are crucial elements of treatment.

Primary Ingredients of Glimpure MV 2.3 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimpure MV 2.3 Tablet

Managing Type 2 diabetes

Major Benefits of Glimpure MV 2.3 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpure MV 2.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

Common Side effects of Glimpure MV 2.3 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimpure MV 2.3 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Glimpure MV 2.3 Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Glimpure MV 2.3 Tablet works:

Each Glimpure MV 2.3 Tablet contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure MV 2.3 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant women may experience adverse effects from Glimpure MV 2.3 Tablet. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and advantages before prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimpure MV 2.3 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glimpure MV 2.3 Tablets is contraindicated in patients with kidney disease and should be avoided. Patients with severe kidney impairment should not take Glimpure MV 2.3 Tablets. Physician consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Glimpure MV 2.3 Tablets cautiously, potentially requiring dose modification. Medical advice is essential. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimpure MV 2.3 Tablet :

Should you forget a Glimpure MV 2.3 Tablet dose, take it immediately if possible. Otherwise, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimpure MV 2.3 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Glimpure MV 2.3 Tablet

Glimpure MV 2.3 Tablet combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus. This medication helps control blood sugar in adults when used with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases liver glucose production and enhances insulin effectiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar. This formulation is unsuitable for type 1 diabetes.
Glimpure MV 2.3 Tablet administration may result in common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal discomfort, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Glimpure MV 2.3 Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Glimpure MV 2.3 Tablets is unsafe. This combination risks exacerbating hypoglycemia and elevating the probability of lactic acidosis.
Indeed, Glimpure MV 2.3 Tablets may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of this side effect increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the container. Discard any leftover medication. Prevent access by children, animals, and unauthorized individuals.
Glimpure MV 2.3 Tablet
106
MRP 129
17% off